Citation Impact
Citing Papers
Memory CD8 + T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection
2003 StandoutNobel
Immunotherapy of chronic hepatitis C virus infection with antibodies against programmed cell death-1 (PD-1)
2013 StandoutNobel
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial
2005 Standout
Heparin-Protein Interactions
2002 Standout
Hepatitis B Virus Infection — Natural History and Clinical Consequences
2004 Standout
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus
2009 StandoutNature
Pathogenesis of hepatitis B virus infection
2010
Chronic Infections with Hepatotropic Viruses: Mechanisms of Impairment of Cellular Immune Responses
2007
Reactive oxygen species and antioxidant machinery in abiotic stress tolerance in crop plants
2010 Standout
Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.
1996 StandoutNobel
The recognition event between virus and host cell receptor: a target for antiviral agents
1990
Delayed Induction, Not Impaired Recruitment, of Specific CD8+ T Cells Causes the Late Onset of Acute Hepatitis C
2011 StandoutNobel
Immunology of hepatitis B virus and hepatitis C virus infection
2005 Standout
A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease
2011 StandoutNobel
Hepatitis B virus infection
2009 Standout
Virus-induced type I IFN stimulates generation of immunoproteasomes at the site of infection
2006 StandoutNobel
Hepatitis B vaccines
2003
Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B.
1998
ROS Function in Redox Signaling and Oxidative Stress
2014 Standout
The RNA Sensor RIG-I Dually Functions as an Innate Sensor and Direct Antiviral Factor for Hepatitis B Virus
2014 StandoutNobel
Reactive oxygen species delay control of lymphocytic choriomeningitis virus
2013
Natural and iatrogenic variation in hepatitis B virus
1999
Impact of solar Ultraviolet-B on the proteome in soybean lines differing in flavonoid contents
2007
Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes
1997
Functional Impairment of CD8+ T Cells by Regulatory T Cells during Persistent Retroviral Infection
2004 StandoutNobel
Characterization of Liver T–Cell Receptor γδ+ T Cells Obtained From Individuals Chronically Infected With Hepatitis C Virus (Hcv): Evidence for These T Cells Playing A Role in the Liver Pathology Associated With Hcv Infections
2001 StandoutNobel
Lethal effect of the anti-Fas antibody in mice
1993 StandoutNature
Mechanisms of HBV-induced hepatocellular carcinoma
2016
Durability of HBeAg seroconversion following antiviral therapy for chronic hepatitis B: relation to type of therapy and pretreatment serum hepatitis B virus DNA and alanine aminotransferase
2003
Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
1995 StandoutNobel
Expression of activation-induced cytidine deaminase in human hepatocytes via NF-κB signaling
2007 StandoutNobel
Restoring function in exhausted CD8 T cells during chronic viral infection
2005 StandoutNatureNobel
Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion.
1992
Virus-induced autoantibody response to a transgenic viral antigen
1990 StandoutNatureNobel
Transient restoration of anti-viral T cell responses induced by lamivudine therapy in chronic hepatitis B
2003
The woodchuck as an animal model for pathogenesis and therapy of chronic hepatitis B virus infection
2007
Assembly of Hepadnaviral Virions and Subviral Particles
1991
B Cell Epitope Mapping of Human Immunodeficiency Virus Envelope Glycoproteins with Long (19- to 36-residue) Synthetic Peptides
1990
Recombinant Human Single Chain Fv Antibodies Recognizing Human Interleukin-6
1998 StandoutNobel
Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen.
1991
Shape‐Controlled Synthesis of Metal Nanocrystals: Simple Chemistry Meets Complex Physics?
2008 Standout
Synthesis and Microcontact Printing of Dual End‐Functionalized Mucin‐like Glycopolymers for Microarray Applications
2009 StandoutNobel
Latent hepatitis B virus infection in healthy individuals with antibodies to hepatitis B core antigen
2000
Hepatitis B Virus Infection of Tupaia Hepatocytes In Vitro And In Vivo
1996
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3
2005 Standout
Exploring the Biological Basis of Hepatitis B E Antigen in Hepatitis B Virus Infection
2003
Direct ex vivo analysis of hepatitis B virus-specific CD8+ T cells associated with the control of infection
1999
Mapping of a Conformational Epitope Shared between E1 and E2 on the Serum-derived Human Hepatitis C Virus Envelope
2003
Click Chemistry In Situ: Acetylcholinesterase as a Reaction Vessel for the Selective Assembly of a Femtomolar Inhibitor from an Array of Building Blocks
2002 StandoutNobel
Hepatitis B virus structure and biology
1989
Kinetics of the Immune Response During Hbv and Hcv Infection
2003
Mathematical modeling of primary hepatitis C infection: Noncytolytic clearance and early blockage of virion production
2005 StandoutNobel
Hepatitis B Virus Biology and Pathogenesis
1992
Replication of hepatitis C virus
2007 StandoutNobel
Serology-Enabled Discovery of Genetically Diverse Hepaciviruses in a New Host
2012 StandoutNobel
Liver-Directed Gamma Interferon Gene Delivery in Chronic Hepatitis C
2005 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Flying Under the Radar: The Immunobiology of Hepatitis C
2006 StandoutNobel
Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor
1993
Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection
2008 StandoutNobel
New Insights into how HBV Manipulates the Innate Immune Response to Establish Acute and Persistent Infection
2013
Characteristics of Hepatitis B Virus Isolates of Genotype G and Their Phylogenetic Differences from the Other Six Genotypes (A through F)
2002
Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients
1996 StandoutNobel
Structure, sequence and expression of the hepatitis delta (δ) viral genome
1986 StandoutNatureNobel
Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.
1995 StandoutNobel
Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160
1993 StandoutNobel
Targeting dendritic cells to enhance DNA vaccine potency.
2001
The hepatitis B virus
1985 Nature
DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans.
1995
Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes
2005 StandoutNobel
Molecular complexes in the isolation and characterization of plasma lipoproteins
1961
Fat Transport in Lipoproteins — An Integrated Approach to Mechanisms and Disorders
1967 Standout
Characterization of Infectious Retroviral Pseudotype Particles Bearing Hepatitis C Virus Glycoproteins
2004 StandoutNobel
Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection
2007
Viral dynamics in hepatitis B virus infection.
1996
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
1994
Kinetics of CD4+and CD8+Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees
2003 StandoutNobel
T- and B-cell recognition of hepatitis B viral antigens
1988
Intralysosomal accumulation of polyanions. I. Fusion of pinocytic and phagocytic vacuoles with secondary lysosomes.
1982 StandoutNobel
Cellular Immune Responses to the Hepatitis B Virus Polymerase
2004
Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein.
1992
RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase
2013 StandoutNobel
Polyvalente Wechselwirkungen in biologischen Systemen: Auswirkungen auf das Design und die Verwendung multivalenter Liganden und Inhibitoren
1998
A splice hepadnavirus RNA that is essential for virus replication.
1996
Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy
1998 StandoutScience
Virus-Specific CD8+Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C
2002
HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen.
1991
Lack of Phenotypic and Functional Impairment in Dendritic Cells from Chimpanzees Chronically Infected with Hepatitis C Virus
2004 StandoutNobel
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
PD-1 and Its Ligands in Tolerance and Immunity
2008 Standout
Erythrocyte P Antigen: Cellular Receptor for B19 Parvovirus
1993 StandoutScience
Works of M.-A. Petit being referenced
In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences
1994
Effect of hepatitis B virus on tumour necrosis factor (TNFα) gene expression in human THP-1 monocytic and Namalwa B-cell lines
1997
Antibodies to synthetic peptides from the pre-S1 and pre-S2 regions of one subtype of the hepatitis B virus (HBV) envelope protein recognize all HBV subtypes
1987
In vivo selection of a hepatitis B virus mutant with abnormal viral protein expression
1996
Antigenic Mapping of the Surface Proteins of Infectious Hepatitis B Virus Particles
1987
Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region
1989
HBc and HBe antigenicity and DNA-binding activity of major core protein P22 in hepatitis B virus core particles isolated from the cytoplasm of human liver cells
1985
Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection.
1990
Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein
1986
Emergence of and takeover by hepatitis B virus (HBV) with rearrangements in the pre-S/S and pre-C/C genes during chronic HBV infection
1991
[Simple determination method for lipids of blood alpha & beta-lipoproteins].
2000
Phosphorylation of the hepatitis B virus core protein by glyceraldehyde-3-phosphate dehydrogenase protein kinase activity.
1998
378 HEPATITIS B CORE (HBC) PROTEIN IS A KEY AND VERY EARLY NEGATIVE REGULATOR OF THE INTERFERON RESPONSE
2013
Defective hepatitis B virus particles are generated by packaging and reverse transcription of spliced viral RNAs in vivo
1991